Veriton Pharma has a board of executive directors and non-executive directors.
Dr. Graham March,
PhD, MRPharmS – Non-Executive Chairman
Dr Graham March is a pharmacist with more than 40 years’ experience gained at major pharmaceutical companies and in the NHS. He has particular expertise in the formulation of tablets, oral liquids and injections and quality control. Prior to founding Veriton Pharma, Dr March was a research pharmacist at Great Ormond Street Hospital for Children, where he developed a number of unlicensed medicines for rare inherited disorders. Earlier in his career, Dr March worked at AstraZeneca, with responsibility for the launch of several products in the UK, after which he was appointed to a number of roles at the Oxford Regional Health Authority.
Dr. Stephen Jones, PhD, MRPharmS
Group Chief Executive Officer
Dr Stephen Jones is a highly experienced pharmaceutical industry executive with a track record in branded medicines and consumer healthcare along with a successful history of new product development. Dr Jones has gained his experience working at major healthcare companies such as GlaxoSmithKline, Sterling Winthrop, Beecham Pharmaceuticals and Merck Sharp & Dohme. His most recent role was with the dermatology company Evocutis plc, where for the previous 6 years he held the post of Chief Executive Officer. In this role, he developed strategic initiatives, managed operational activities and negotiated commercial relationships.